A role for IP-10 in LN is implicated from several reports showing enhanced IP-10 mRNA or protein levels in serum, urine, kidney biopsies, or circulating immune cells in patients with SLE with active LN [9,10,11,12,13]. Here, CXCL10 is linked to systemic lupus erythematosus.